# Jennifer Byrne

> Jennifer Byrne is the founder, CEO and board director of Javara, a Winston-Salem clinical research company that embeds trial teams inside healthcare organizations. A Texas A&M graduate who began as a clinical research coordinator after mistakenly expecting a pharmaceutical sales job, Byrne rose through PMG Research to become its CEO, founded the nonprofit Greater Gift, and then co-founded Javara in 2018 to make clinical trials more visible and accessible through trusted care settings.

- **Role:** Founder, CEO and Board Director at Javara
- **Organizations:** Javara, PMG Research, Greater Gift, Association of Clinical Research Professionals, CISCRP, Wake Forest University, Wake Forest Institute for Regenerative Medicine, Piedmont Triad Regenerative Medicine Engine
- **Nationality:** American
- **Education:** Bachelor's degree in scientific nutrition, Texas A&M University, Doctor of Humane Letters, honoris causa, Salem College
- **Known for:** Contributed to more than 8,000 clinical trials across her career., Co-founded Javara and helped establish its integrated research organization model., Founded Greater Gift, which reports celebrating more than 178,000 clinical research participants since 2010.

## Career timeline

- **1989** — Moved to Winston-Salem to join PMG Research after beginning her clinical research career in Texas.
- **c. 2007-2017** — Served for nearly ten years as CEO of PMG Research after earlier roles as site manager and vice president of operations.
- **2010** — Founded Greater Gift to recognize clinical research participants through donations made in their honor.
- **2013** — Named one of CenterWatch's 20 Innovators Changing the Face of the Clinical Trials Industry.
- **2017** — Stepped down as PMG Research CEO and spent about a year leading Greater Gift and speaking with health-system leaders.
- **2018** — Co-founded Javara with Amanda Wright and Linda McCarty to embed clinical research into healthcare delivery.
- **2021** — Named a PharmaVOICE Woman of Influence.
- **2024** — Delivered Salem College's commencement address and received an honorary Doctor of Humane Letters.
- **2025** — Javara disclosed a $6.6 million Series C offering; Byrne described the investment as support for accelerated growth.
- **2026** — Javara was named to the 2026 Inc. 5000 list.

## Achievements

- Contributed to more than 8,000 clinical trials across her career.
- Co-founded Javara and helped establish its integrated research organization model.
- Founded Greater Gift, which reports celebrating more than 178,000 clinical research participants since 2010.
- Recognized as a PM360 ELITE, CenterWatch Top 20 Innovator and PharmaVOICE Woman of Influence.
- Named a Triad Business Journal Power Player twice and an Outstanding Woman in Business.
- Received an honorary Doctor of Humane Letters from Salem College in 2024.

## Latest updates

- **2026-08** — Javara was named to the 2026 Inc. 5000 list of fast-growing private U.S. companies.
- **2026-01** — Byrne discussed the 'invisibility problem' of clinical trials and the role of trust and infrastructure on The Healthcare Theory podcast.
- **2025-05** — Javara disclosed a $6.6 million Series C offering to support growth and therapeutic expansion.
- **2025-05** — Became a board member of the Association of Multisite Research Corporations.
- **2024-05** — Delivered Salem College's commencement address and received an honorary Doctor of Humane Letters.

## Links

- Website: https://javararesearch.com
- LinkedIn: https://www.linkedin.com/in/jenniferjbyrne

---

Profile page: https://yespress.io/jennifer-byrne
Published by YesPress — https://yespress.io
Last updated: 2026-09-27